作者:
Devogelaere,B. [1]
;
Berke,J.M. [2]
;
Vijgen,L. [3]
;
Dehertogh,P. [4]
;
Fransen,E. [5]
;
Cleiren,E. ;
VanDerHelm,L. ;
Nyanguile,O. ;
Tahri,A. ;
Amssoms,K. ;
Lenz,O. ;
Cummings,M.D. ;
Clayton,R.F. ;
Vendeville,S. ;
Raboisson,P. ;
Simmen,K.A. ;
Fanning,G.C. ;
Lin,T.-I.
作者单位:
Janssen Infectious Diseases, Beerse, Belgium
[1]
Janssen Infectious Diseases, Beerse, Belgium, University of Applied Sciences, Institute of Life
[2]
Janssen Infectious Diseases, Beerse, Belgium, BioReliance Ltd., Glasgow, United Kingdom
[3]
Janssen Infectious Diseases, Beerse, Belgium, Biocartis NV, Mechelen, Belgium
[4]
Johnson and Johnson Pharmaceutical Research and Development, Springhouse, PA, United States
[5]
发布时间
2013-11-20